{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:37:07Z","timestamp":1794004627696,"version":"4.8.0"},"reference-count":29,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Adult patients with ETP-ALL\/LBL have poor long-term outcomes. Novel therapies are urgently needed for adult patients with ETP-ALL\/LBL.<\/jats:p>","DOI":"10.1182\/blood-2015-08-661702","type":"journal-article","created":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T04:14:27Z","timestamp":1452312867000},"page":"1863-1869","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":315,"title":["Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype"],"prefix":"10.1182","volume":"127","author":[{"given":"Nitin","family":"Jain","sequence":"first","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey V.","family":"Lamb","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Ravandi","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Konopleva","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Jabbour","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Pierce","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rytting","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Borthakur","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Kadia","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[{"name":"Department of Leukemia and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2019111906230768100_B1","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias.","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"issue":"2","key":"2019111906230768100_B2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0950-3536(05)80201-X","article-title":"Immunophenotypic classification of acute lymphoblastic leukaemia.","volume":"7","author":"Ludwig","year":"1994","journal-title":"Baillieres Clin Haematol"},{"issue":"Suppl 1","key":"2019111906230768100_B3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/10428199409052679","article-title":"Immunophenotypic features of childhood and adult acute lymphoblastic leukemia (ALL): experience of the German Multicentre Trials ALL-BFM and GMALL.","volume":"13","author":"Ludwig","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"2019111906230768100_B4","first-page":"176","article-title":"T Lymphoblastic Leukemia\/Lymphoma.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Borowitz","year":"2008"},{"issue":"2","key":"2019111906230768100_B5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"issue":"7380","key":"2019111906230768100_B6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"issue":"7188","key":"2019111906230768100_B7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature06840","article-title":"The earliest thymic progenitors for T cells possess myeloid lineage potential.","volume":"452","author":"Bell","year":"2008","journal-title":"Nature"},{"issue":"7188","key":"2019111906230768100_B8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature06839","article-title":"Adult T-cell progenitors retain myeloid potential.","volume":"452","author":"Wada","year":"2008","journal-title":"Nature"},{"key":"2019111906230768100_B9","doi-asserted-by":"crossref","article-title":"T-lymphoblastic leukemia (T-ALL) shows excellent outcome, lack of significance of the early thymic precursor (ETP) immunophenotype, and validation of the prognostic value of end-induction minimal residual disease (MRD) in Children\u2019s Oncology Group (COG) Study AALL0434.","author":"Wood","DOI":"10.1182\/blood.V124.21.1.1"},{"issue":"1","key":"2019111906230768100_B10","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1038\/bcj.2011.49","article-title":"Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.","volume":"2","author":"Neumann","year":"2012","journal-title":"Blood Cancer J"},{"issue":"1","key":"2019111906230768100_B11","doi-asserted-by":"crossref","first-page":"e53190","DOI":"10.1371\/journal.pone.0053190","article-title":"FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.","volume":"8","author":"Neumann","year":"2013","journal-title":"PLoS One"},{"issue":"23","key":"2019111906230768100_B12","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","article-title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations.","volume":"121","author":"Neumann","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2019111906230768100_B13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.2011.08955.x","article-title":"Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children\u2019s Cancer Study Group Study L99-15.","volume":"156","author":"Inukai","year":"2012","journal-title":"Br J Haematol"},{"issue":"Suppl 3","key":"2019111906230768100_B14","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.3816\/CLM.2009.s.015","article-title":"T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?","volume":"9","author":"Hoelzer","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"issue":"25","key":"2019111906230768100_B15","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","article-title":"T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993).","volume":"114","author":"Marks","year":"2009","journal-title":"Blood"},{"key":"2019111906230768100_B16","doi-asserted-by":"crossref","article-title":"Successful subtype oriented treatment strategies in adult T-All; results of 744 patients treated in three consecutive GMALL studies.","author":"Hoelzer","DOI":"10.1182\/blood.V114.22.324.324"},{"issue":"4","key":"2019111906230768100_B17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/leu.2013.312","article-title":"The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience.","volume":"28","author":"Jain","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"2019111906230768100_B18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clml.2014.01.002","article-title":"The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.","volume":"14","author":"Zhou","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"2019111906230768100_B19","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","article-title":"Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.","volume":"101","author":"Kantarjian","year":"2004","journal-title":"Cancer"},{"issue":"23","key":"2019111906230768100_B20","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1002\/cncr.28930","article-title":"Augmented Berlin-Frankfurt-M\u00fcnster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).","volume":"120","author":"Rytting","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"2019111906230768100_B21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2005-04-1754","article-title":"Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.","volume":"107","author":"Vitale","year":"2006","journal-title":"Blood"},{"key":"2019111906230768100_B22","doi-asserted-by":"crossref","article-title":"Favorable outcome in a large cohort of prospectively treated adult patients with T-lymphoblastic lymphoma (T-LBL) despite slowly evolving complete remission assessed by conventional radiography.","author":"G\u00f6kbuget","DOI":"10.1182\/blood.V124.21.370.370"},{"key":"2019111906230768100_B23","article-title":"Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 study [published online ahead of print December 7, 2015.].","author":"Lepretre","journal-title":"J Clin Oncol"},{"key":"2019111906230768100_B24","doi-asserted-by":"crossref","article-title":"Patients with early T-cell precursor (ETP) acute lymphoblastic leukemia (ALL) have high levels of minimal residual disease (MRD) at the end of induction\u2013A Children\u2019s Oncology Group (COG) Study.","author":"Wood","DOI":"10.1182\/blood.V114.22.9.9"},{"issue":"3","key":"2019111906230768100_B25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.12882","article-title":"Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.","volume":"166","author":"Patrick","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111906230768100_B26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.","volume":"122","author":"Van Vlierberghe","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2019111906230768100_B27","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","article-title":"Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199.","volume":"4","author":"Chonghaile","year":"2014","journal-title":"Cancer Discov"},{"issue":"25","key":"2019111906230768100_B28","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia.","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2019111906230768100_B29","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","article-title":"Efficacy of JAK\/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/15\/1863\/1392608\/1863.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/15\/1863\/1392608\/1863.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T11:30:16Z","timestamp":1574163016000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/127\/15\/1863\/34809\/Early-Tcell-precursor-acute-lymphoblastic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-08-661702","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,14]]}}}